Sign in
Subscribe
News
Tech trail
Trade floor
Export
The killer50
Blogs
Awards
Directory
Events
A worldwide window to Cambridge business, innovation and technology
LoQus23 Therapeutics raises £35m to fight Huntington’s disease
Cambridge biotech LoQus23 Therapeutics has closed a £35 million (c.$43m) Series A to advance its fight against Huntington’s disease.
Game-changing AI camera launched by Raspberry Pi and Sony
Japan’s Sony Semiconductor Solutions Corporation (SSS) and Cambridge UK quoted company Raspberry Pi have launched a jointly developed AI camera.
Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal
Cambridge-based online fraudbuster Featurespace is to be acquired by San Francisco company Visa – quoted on the New York Stock Exchange – for an undisclosed sum. Business Weekly has fielded reports from California that Visa could pay close to $1 billion.
Raspberry Pi wows the market with blistering first half and reveals further innovation uptick
Cambridge based Raspberry Pi, a leader in low-cost, high-performance computing, has produced stronger than expected first half results which have prompted stockholders to sit up and take notice.
Winter of great content: Sir Greg joins board as Constructive Bio takes funding haul to $75m
Constructive Bio, a Cambridge based synthetic genomics company, has raised $58 million in the first close of a Series A financing, bringing the total amount secured by the company to date to $75m.
Academia
Sharewatch
Manufacturing
Finalists chosen to pitch at Norwich innovation showcase
07 Oct 2024 - 12:00
Cambridge showcase aims to supercharge female entrepreneurship
19 Sep 2024 - 12:00
Cambridge team claims MedTech world first
18 Sep 2024 - 12:00
Business awards
Entries now being accepted
Business directory
Browse our listings of Cambridge companies
The killer 50
The 50 hottest disruptive technology companies
News
Microbiotica progresses melanoma trial
Wellcome Sanger Institute spin-out Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), has announced that the first patient has been dosed in its advanced melanoma (MELODY-1) trial.
Ex-AstraZeneca ace fits executive pattern for Mosaic
Cambridge-based Mosaic Therapeutics has appointed ex-AstraZeneca director Dr Barry Davies as CSO.
Finalists chosen to pitch at Norwich innovation showcase
Eight entrepreneurs have been selected to pitch their business ideas to judges at The Norwich Research Park Innovation Hothouse Competition. The pitching session will happen at the Enterprise Tuesday event being held on the 26th November at the John Innes Conference Centre on Norwich Research Park.
Stansted wins Airport of the Year crown at UK National Transport Awards
London Stansted has been named Airport of the Year at the UK National Transport Awards 2024.
More news
Tech trail
LoQus23 Therapeutics raises £35m to fight Huntington’s disease
Cambridge biotech LoQus23 Therapeutics has closed a £35 million (c.$43m) Series A to advance its fight against Huntington’s disease.
J.P. Morgan and CIC leverage Cambridge Entrepreneurs Forum to inspire future growth
Last week, in partnership with Cambridge Innovation Capital, J.P. Morgan hosted its annual Cambridge Entrepreneurs Forum, bringing together J.P. Morgan’s leading multi-disciplinary capabilities to address the opportunities and challenges of scaling up ambitious UK companies with a global outlook.
From £8m to more than £100m and NetScientific becomes EMV Capital
AIM-quoted NetScientific Plc, a DeepTech and life sciences VC investment group with Cambridge facilities, has changed its name to EMV Capital plc.
Evoralis textile recycling revolution could unlock $560bn opportunity
Cambridge University spin-out Evoralis has raised £2.5 million seed funding to fast-track development of technology to recycle textiles and plastics previously deemed unrecyclable. It literally has LIFTT-off! And this particular ‘seed’ also has massive growth potential: The £2.5m round could unlock a $560 billion economic opportunity!
More Tech trail
Trade floor
Tessellate BIO in historic cancer research initiative
Tessellate BIO, which has research labs at the Stevenage Bioscience Catalyst, has joined forces with Australasian power players Omico and Children's Medical Research Institute (CMRI) to initiate groundbreaking cancer research.
Cambridge the honey pot for US again as Visa swoops for Featurespace in c$1bn deal
Cambridge-based online fraudbuster Featurespace is to be acquired by San Francisco company Visa – quoted on the New York Stock Exchange – for an undisclosed sum. Business Weekly has fielded reports from California that Visa could pay close to $1 billion.
Cambridge easy prey for big bucks buyers from US
Featurespace’s impending sale to Visa is just the latest in a series of acquisitions of world-leading Cambridge technology companies by big bucks US buyers in recent months.
Howes Percival acts for SecAlliance on sale to Danish company
Lawyers at Howes Percival’s Milton Keynes office have advised UK headquartered Security Alliance Limited (SecAlliance) on its acquisition by CSIS Security Group A/S in Denmark. Howes Percival advised the sellers, John Beale and Robert Dartnall on all aspects of the transaction.
PlaqueTec and RxCelerate a force for change in drug screening
An alliance between Cambridge duo PlaqueTec and RxCelerate promises huge gains for global drug hunters.
More Trade floor
